Cingulate Therapeutics
Jay Roberts serves as Treasurer and a Board of Trustees member at US Pharmacopeia, providing financial oversight and governance for an organization that sets global quality standards for medicines and dietary supplements. As a Partner at Ventac Partners, Roberts contributes to the development of innovative life science companies. In addition, Roberts is a member of the Board of Directors at Cingulate Inc. and Caidya, and holds positions as Managing Partner at DigiLife Funds and Board Member at Navipoint Health, Inc. and VeriSkin, Inc. Furthermore, Roberts has been part of Vyant Bio's Board since April 2018 and serves as an Executive Board Member for Fight Cancer Global, focusing on enhancing information access in the cancer care sector. As a Fellow at the Drug Information Association, Roberts supports efforts to provide life-saving medicines globally. Academic credentials include an MBA in Finance from the University of Maine.
This person is not in any teams
This person is not in any offices
Cingulate Therapeutics
1 followers
Cingulate® is a biopharmaceutical company utilizing its innovative Precision Timed Release™ (PTR) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products.